| 摘要 |
<p>This invention relates to the use of the baculovirus glycoprotein, Interferon Stimulating Protein (ISP) (also known as gp67, gp64 EFP, or gp64), or the gene sequence encoding ISP, to stimulate production of interferon, such as for immunotherapy, anti-viral, anti-cancer, anti-bacterial, or anti-parasitic therapy. This invention also relates to novel mutants forms of ISP that show enhanced biological (i.e., anti-viral) activity, increased stability, higher yield or better solubility.</p> |
